MIBC Clinical Trials in Shanghai, Shanghai Municipality
4 recruitingShanghai, Shanghai Municipality, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital25 enrolled12 locationsNCT07296705
Recruiting
Phase 2Phase 3
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
Muscular Invasive Bladder Cancer (MIBC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.840 enrolled1 locationNCT06879145
Recruiting
Not Applicable
Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer
NMIBC
Changhai Hospital72 enrolled1 locationNCT06889623
Recruiting
Phase 1
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Jiangsu Simcere Pharmaceutical Co., Ltd.152 enrolled14 locationsNCT06186414